KR20100025303A - Functional beverage composition in which the function of ginseng saponin is augmented - Google Patents
Functional beverage composition in which the function of ginseng saponin is augmented Download PDFInfo
- Publication number
- KR20100025303A KR20100025303A KR1020080084011A KR20080084011A KR20100025303A KR 20100025303 A KR20100025303 A KR 20100025303A KR 1020080084011 A KR1020080084011 A KR 1020080084011A KR 20080084011 A KR20080084011 A KR 20080084011A KR 20100025303 A KR20100025303 A KR 20100025303A
- Authority
- KR
- South Korea
- Prior art keywords
- ginseng
- ginsenoside
- beverage composition
- functional beverage
- extract
- Prior art date
Links
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 51
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 49
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 49
- 229930182490 saponin Natural products 0.000 title claims abstract description 30
- 150000007949 saponins Chemical class 0.000 title claims abstract description 30
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 23
- 239000001397 quillaja saponaria molina bark Substances 0.000 title claims abstract description 22
- 241000208340 Araliaceae Species 0.000 title claims abstract 12
- 230000003190 augmentative effect Effects 0.000 title 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims abstract description 42
- 235000013361 beverage Nutrition 0.000 claims abstract description 31
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 20
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 claims abstract description 19
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims abstract description 19
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 claims abstract description 19
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 claims abstract description 19
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002562 thickening agent Substances 0.000 claims abstract description 5
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 3
- 235000012907 honey Nutrition 0.000 claims abstract description 3
- 239000003765 sweetening agent Substances 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 15
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 9
- 230000002929 anti-fatigue Effects 0.000 claims description 8
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 6
- 229930064664 L-arginine Natural products 0.000 claims description 6
- 235000014852 L-arginine Nutrition 0.000 claims description 6
- 235000002789 Panax ginseng Nutrition 0.000 claims description 6
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 210000005036 nerve Anatomy 0.000 claims description 4
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 3
- 244000241838 Lycium barbarum Species 0.000 claims description 3
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 3
- 206010039897 Sedation Diseases 0.000 claims description 3
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 3
- 230000002082 anti-convulsion Effects 0.000 claims description 3
- 230000036772 blood pressure Effects 0.000 claims description 3
- 235000017803 cinnamon Nutrition 0.000 claims description 3
- 230000003340 mental effect Effects 0.000 claims description 3
- 230000036280 sedation Effects 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 2
- 235000015468 Lycium chinense Nutrition 0.000 claims description 2
- 244000273928 Zingiber officinale Species 0.000 claims description 2
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 2
- 230000036592 analgesia Effects 0.000 claims description 2
- 235000006533 astragalus Nutrition 0.000 claims description 2
- 235000008397 ginger Nutrition 0.000 claims description 2
- 229940010454 licorice Drugs 0.000 claims description 2
- 210000004233 talus Anatomy 0.000 claims description 2
- 241000283074 Equus asinus Species 0.000 claims 1
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 1
- 239000012676 herbal extract Substances 0.000 claims 1
- 229930182494 ginsenoside Natural products 0.000 abstract description 17
- 229940089161 ginsenoside Drugs 0.000 abstract description 8
- 150000001875 compounds Chemical class 0.000 abstract 1
- 240000004371 Panax ginseng Species 0.000 description 40
- 235000017709 saponins Nutrition 0.000 description 25
- 238000002360 preparation method Methods 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- PVLHOJXLNBFHDX-XHJPDDKBSA-N Panaxadiol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(CC[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 PVLHOJXLNBFHDX-XHJPDDKBSA-N 0.000 description 6
- SYFJYASKXNAXKC-UHFFFAOYSA-N Panaxadiol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CCC34C SYFJYASKXNAXKC-UHFFFAOYSA-N 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000020509 fortified beverage Nutrition 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- VCNKUCWWHVTTBY-UHFFFAOYSA-N 18alpha-Oleanane Natural products C1CCC(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4CCC3C21C VCNKUCWWHVTTBY-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- SIOMFBXUIJKTMF-UHFFFAOYSA-N hypoglauterpenic acid Natural products C1CC(O)C(C)(C)C2=CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C SIOMFBXUIJKTMF-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BPAWXSVOAOLSRP-UHFFFAOYSA-N oleanane Natural products CCCCCCCCCCCCCCCC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5CC(C)(C)CCC5(C)C(O)CC34C)C1(C)C BPAWXSVOAOLSRP-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/27—Xanthan not combined with other microbial gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/272—Gellan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/273—Dextran; Polysaccharides produced by leuconostoc
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5036—Carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5042—Dextran
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5054—Gellan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5072—Pectine, pectinate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5086—Xanthan
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
본 발명은 인삼 사포닌을 포함하는 기능성 음료 조성물에 관한 것으로, 보다 구체적으로는 인삼 사포닌의 기능이 선택적으로 강화된 기능성 음료 조성물에 관한 것이다. The present invention relates to a functional beverage composition comprising ginseng saponin, and more particularly to a functional beverage composition wherein the function of ginseng saponin is selectively enhanced.
인삼(Panax ginseng C.A. Mayer)은 식물학적으로 오갈피나무과(Araliaceae) 인삼속에 속하는 식물로써, 중국에서는 기원전부터 약용으로 사용되었고, 국내에서는 삼국시대부터 인삼을 교역, 약용으로 사용되어 왔으며, 현재까지도 여러 분야에 한약재나 건강식품으로 널리 사용 중에 있다. Ginseng (Panax ginseng CA Mayer) is botanically belonging to the genus Araliaceae ginseng, which has been used for medicinal purposes in China since BC, and has been used for trade and medicinal use in Korea since the Three Kingdoms. It is widely used as a herbal medicine or health food.
인삼에는 종(種) 특이적인 성분으로서 진세노사이드 (ginsenoside)라는 사포닌 유사 물질이 약 3-6% 함유되어 있으며, 이는 인삼의 대표적인 생리활성 물질로써, 구조에 따라 파낙사디올계(Panaxadiol: PD)와 파낙사트리올계(Panaxatriol: PT), 올레아난계(Oleanane)로 나뉘며 약 33종이 보고되어 있다. Ginseng contains about 3-6% of ginsenoside-like saponin-like substance as a species-specific component, which is a representative physiologically active substance of ginseng, depending on the structure of panaxadiol (PD). ), And panaxhatriol (PT) and oleanane (Oleanane) divided into about 33 species have been reported.
PD계 사포닌과 PT계 사포닌은 체내에서 각기 다른 작용을 한다. 진세노사이드 Rb1으로 대표되는 PD계 사포닌은 중추신경에 대한 억제작용을 나타내어 정신안 정, 신경이완, 진통, 항경련, 혈압강하, 파파베린양 작용 등을 나타내는 것으로 알려져 있다. 이에 반해, 진세노사이드 Rg1으로 대표되는 PT계 사포닌은 중추신경에 대해 흥분적으로 작용하여, 항피로작용이 있는 것으로 알려져 있다. 인삼의 Rb1/Rg1의 비율은 수확시기, 경작지, 부위에 따라 달라질 수 있는 것으로 보고되고 있으나, 한국인삼연초연구원의 1996년 연구결과로는 일반적으로 고려인삼(백삼)의 Rb1/Rg1의 비율을 1.3 정도라고 보고하고 있다. PD-based saponins and PT-based saponins have different functions in the body. PD-based saponins, represented by ginsenoside Rb1, are known to exhibit inhibitory effects on the central nervous system, resulting in mental stability, nerve relaxation, analgesia, anticonvulsions, lowering blood pressure, papaverine-like action. In contrast, PT-based saponins, represented by ginsenoside Rg1, are known to have an anti-fatigue effect by acting excitably on the central nerve. Although the ratio of Rb1 / Rg1 of ginseng may vary according to harvest time, cropland, and area, Korea Ginseng and Tobacco Research Institute's 1996 research generally shows that the ratio of Rb1 / Rg1 of Korean ginseng (white ginseng) is 1.3 It is reported.
종래의 진세노사이드 관련 연구들은 인삼 내에서 미량 존재하는 성분들의 함량을 증가시키는 방법이나(US 7,371,416) 진세노사이드의 특정 질환치료 용도(WO 01/056585)에 대한 연구가 주를 이루고 있으며, 다양한 종류의 진세노사이드의 개별적인 효능이 증대된 조성물을 소비자가 선택하여 원하는 효과를 얻을 수 있도록 한 조성물에 대해서는 개발된 바가 없다. Previous studies on ginsenosides have focused on increasing the amount of trace elements present in ginseng (US 7,371,416) or research on the use of ginsenosides for treating certain diseases (WO 01/056585). No composition has been developed that allows the consumer to select a composition with enhanced individual efficacy of the ginsenosides of the kind to achieve the desired effect.
인삼 내에 존재하는 PD계 사포닌과 PT계 사포닌은 서로 반대 작용을 나타내므로, PD계 사포닌과 PT계 사포닌의 비율에 따라서 인삼은 신체 내에서는 각기 다른 작용이 일어날 수 있다. 또한, 인삼의 추출물을 포함하는 조성물에 있어서도 추출물에 존재하는 Rb1/Rg1의 비율에 따라 다른 작용이 나타날 수 있고, Rb1 및 Rg1의 서로 상반된 경향의 작용에 의해 인삼 추출물로부터 각각의 사포닌이 발휘하는 효과를 효율적으로 얻을 수 없는 단점이 있다. 더욱이, 의료인의 전문적인 감독 하에 있지 않는 특별한 질병이 없는 사람들이 평상시 즐겨 마시는 건강 기능성 음료에 있어서는 원하지 않는 효과를 갖는 음료를 부지불식간에 섭취할 수 있어 특히 문제가 된다. Since PD-based saponins and PT-based saponins present in ginseng have opposite effects, ginseng may have different effects in the body depending on the ratio of PD-based saponins and PT-based saponins. In addition, even in a composition comprising an extract of ginseng, different actions may be shown depending on the ratio of Rb1 / Rg1 present in the extract, and the effect of each saponin exerted from the ginseng extract by the action of opposite tendencies of Rb1 and Rg1. There is a disadvantage that can not be obtained efficiently. Moreover, it is particularly problematic for those who do not have special illnesses not under the professional supervision of a medical professional to inadvertently ingest beverages that do not have an undesirable effect on their usual functional health drink.
이에, 본 발명자들은 이러한 인삼 사포닌 추출물의 단점이 보완된 새로운 음료 조성물의 필요성을 인식하고, 서로 상반된 효과를 나타내는 인삼 사포닌 Rb1 또는 Rg1의 효능을 선택적으로 얻을 수 있으며, 인삼 사포닌의 안정성을 강화시켜 최종적으로 소비자가 섭취 시 원하는 인삼 사포닌 효과를 신뢰성 있게 얻을 수 있는 음료 조성물을 개발하기 위해 연구한 결과 본 발명을 완성하게 되었다.Accordingly, the present inventors recognize the necessity of a new beverage composition that is compensated for the disadvantages of the ginseng saponin extract, can selectively obtain the efficacy of the ginseng saponin Rb1 or Rg1 showing the opposite effect, and enhance the stability of the ginseng saponin to finally As a result of research to develop a beverage composition that can reliably obtain the ginseng saponin effect desired by the consumer when ingested, the present invention was completed.
따라서, 본 발명의 목적은 인삼 사포닌의 개별적인 효능이 선택적으로 강화되고 사포닌의 안정성이 증가된 음료 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a beverage composition in which the individual efficacy of ginseng saponin is selectively enhanced and the stability of saponin is increased.
상기 목적을 달성하기 위해, 본 발명은 진세노사이드 Rb1의 진세노사이드 Rg1에 대한 비율(Rb1/Rg1)이 2 이상인 인삼 추출물을 포함하는 인삼 사포닌의 진정작용이 강화된 기능성 음료 조성물을 제공한다. In order to achieve the above object, the present invention provides a functional beverage composition for strengthening the sedation of ginseng saponin including ginseng extract having a ratio (Rb1 / Rg1) of ginsenoside Rb1 to ginsenoside Rg1 is two or more.
본 발명은 또한, 진세노사이드 Rg1의 진세노사이드 Rb1에 대한 비율(Rg1/Rb1)이 0.5 이상인 인삼 추출물을 포함하는 인삼 사포닌의 항피로기능이 강화된 기능성 음료 조성물을 제공한다. The present invention also provides a functional beverage composition having enhanced anti-fatigue function of ginseng saponin, including ginseng extract having a ratio of ginsenoside Rg1 to ginsenoside Rb1 (Rg1 / Rb1) of 0.5 or more.
이하, 본 발명을 보다 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명은 인삼의 특이적인 성분인 진세노사이드의 함량비를 조정한 음료 조성물에 관한 것으로서, 인삼 유래의 진세노사이드를 추출, 정제, 및 강화의 방법을 사용하여 함량비를 변경하고 이를 표준화 한 것을 주원료로 사용하여, 기존의 인삼 추출액을 함유하는 음료와 달리 소비자가 인삼 중의 원하는 효과를 선택적으로 갖는 음료를 선택할 수 있도록 인삼 사포닌 중의 특정 성분이 강화된 인삼 기능성 음료를 제공한다. 구체적으로, 본 발명은 인삼 추출물 중의 진세노사이드 Rb1 및 Rg1의 상대적인 비율을 달리하여, 진세노사이드 Rb1의 효능인 중추신경억제기능이 강화되거나, 진세노사이드 Rg1의 효능인 항피로기능이 강화된 음료 조성물에 관한 것이다. The present invention relates to a beverage composition in which the content ratio of ginsenoside, which is a specific component of ginseng, is adjusted, and the content ratio is changed and standardized by extracting, purifying, and strengthening ginsenosides derived from ginseng. It is used as the main raw material, unlike conventional beverages containing ginseng extracts to provide a ginseng functional beverage fortified with a specific component in ginseng saponin so that consumers can choose a beverage having a desired effect in the ginseng. Specifically, the present invention by varying the relative ratio of ginsenosides Rb1 and Rg1 in the ginseng extract, the central nervous system inhibitory function of the ginsenoside Rb1 is enhanced, or the anti-fatigue function of the ginsenoside Rg1 is enhanced It relates to a beverage composition.
따라서, 본 발명의 일 측면에 있어서, 본 발명은 진세노사이드 Rb1의 진세노사이드 Rg1에 대한 비율(Rb1/Rg1)이 2 이상인 인삼 추출물 분획을 포함하는 인삼 사포닌의 진정 기능이 강화된 기능성 음료 조성물을 제공한다. 상기 조성물은 진세노사이드 Rb1이 Rg1에 비해 2 배 이상 함유되어 인삼 추출물의 사포닌의 효과 중 특히 Rb1의 중추신경억제기능에 의한 진정 기능이 강화된 음료 조성물이다. 따라 서, 정신안정, 신경이완, 진통, 항경련, 또는 혈압강하에 대한 효과가 증진된 음료 조성물이다. 상기 진정 기능을 더욱 강화시키기 위해, 상기 음료 조성물은 바람직하게는 진세노사이드 Rb1을 Rg1에 비해 10 배 이상 함유할 수 있다. 상기 음료조성물은 진세노사이드 Rb1은 0.2-30 mg/g, 진세노사이드 Rg1은 0.1-10 mg/g의 함량으로 포함할 수 있다.Therefore, in one aspect of the present invention, the present invention provides a functional beverage composition for enhancing the sedation function of ginseng saponin comprising a ginseng extract fraction having a ratio (Rb1 / Rg1) of ginsenoside Rb1 to ginsenoside Rg1 of 2 or more. To provide. The composition is a beverage composition in which ginsenoside Rb1 is contained two times or more than Rg1, and among the effects of saponin of the ginseng extract, in particular, the soothing function is enhanced by the central nervous inhibitory function of Rb1. Therefore, it is a beverage composition with enhanced effects on mental stability, nerve relaxation, analgesic, anticonvulsion, or lowering blood pressure. To further enhance the soothing function, the beverage composition may preferably contain 10 times more ginsenoside Rb1 than Rg1. The beverage composition may comprise a ginsenoside Rb1 of 0.2-30 mg / g, ginsenoside Rg1 of 0.1-10 mg / g.
본 발명의 다른 측면에 있어서, 본 발명은 진세노사이드 Rg1의 진세노사이드 Rb1에 대한 비율(Rg1/Rb1)이 0.5 이상인 인삼 추출물을 포함하는 인삼 사포닌의 항피로기능이 강화된 기능성 음료 조성물을 제공한다. 상기 조성물은 진세노사이드 Rg1이 Rb1에 비해 0.5 배 이상 함유되어 인삼 추출물의 사포닌의 효과 중 특히 Rg1의 중추신경흥분 작용에 의한 항피로 기능이 강화된 음료 조성물이다. 상기 항피로 기능을 더욱 강화시키기 위해, 상기 음료 조성물은 바람직하게는 진세노사이드 Rg1을 Rb1에 비해 10 배 이상 함유할 수 있다. 상기 음료조성물은 진세노사이드 Rg1은 0.1-30 mg/g, 진세노사이드 Rb1은 0.2-30 mg/g의 함량으로 포함할 수 있다. In another aspect of the present invention, the present invention provides a functional beverage composition for enhanced anti-fatigue function of ginseng saponin comprising ginseng extract ratio of ginsenoside Rg1 to ginsenoside Rb1 (Rg1 / Rb1) is 0.5 or more. do. The composition is a beverage composition in which ginsenoside Rg1 is contained at least 0.5 times than Rb1, and among the effects of saponin of the ginseng extract, in particular, the anti-fatigue function by the central nervous system excitement effect of Rg1. In order to further enhance the anti-fatigue function, the beverage composition may preferably contain 10 times more ginsenoside Rg1 than Rb1. The beverage composition may comprise 0.1-30 mg / g ginsenoside Rg1, 0.2-30 mg / g ginsenoside Rb1.
상기 중추신경억제 기능이 강화된 기능성 음료 조성물 및 항피로 기능이 강화된 기능성 음료 조성물에 함유되는 인삼 추출물은 Rb1의 진세노사이드 Rg1에 대한 비율(Rb1/Rg1) 2 또는 Rg1의 진세노사이드 Rb1에 대한 비율(Rg1/Rb1)이 0.5 이상인 추출물로서, 이와 같이 Rb1 또는 Rg1의 비율이 높은 인삼 추출물은 인삼의 원물 또는 인삼의 농축액을 물, 주정, 또는 이들의 혼합물을 용매로 하고 이온교환수지 등을 이용하여 추출, 분리, 정제, 및 강화의 방법을 이용하여 제조할 수 있으며, 이는 당해 기술분야의 통상의 지식을 가진 자에게 잘 알려져 있다(곽이성 등, 홍삼유출액으로부터 Diaion HP-20수지 흡착법에 의한 조사포닌의 분리, 2001년, 한국식품영양과학회지). 상기 인삼 추출물의 제조에 이용되는 인삼 또는 인삼 농축액은 사포닌 Rb1 또는 Rg1이 함유되어 있는 임의의 인삼 또는 그 농축액이 이용될 수 있으며, 예를 들어 백삼, 수삼, 홍삼, 태극삼, 흑삼, 호정화 인삼(퍼핑 인삼), 또는 효소처리 인삼이나 그 농축액이 이용될 수 있다.The ginseng extract contained in the functional beverage composition and the anti-fatigue-enhanced functional beverage composition having enhanced central nervous system suppression function is a ratio of Rb1 to ginsenoside Rg1 (Rb1 / Rg1) 2 or Rg1 to ginsenoside Rb1. A ginseng extract with a high ratio of Rb1 or Rg1, wherein the extract of the ginseng extract or the concentrate of ginseng is water, alcohol, or a mixture thereof as a solvent, and an ion exchange resin is used. Can be prepared using methods of extraction, separation, purification, and fortification, which are well known to those of ordinary skill in the art (Kwak Sung et al., From Red ginseng effluent to Diaion HP-20 resin adsorption method). Separation of Irradiated Ponine by Korean Society of Food and Nutrition. The ginseng or ginseng concentrate used in the preparation of the ginseng extract may be any ginseng containing saponin Rb1 or Rg1 or a concentrate thereof, for example, white ginseng, ginseng, red ginseng, taeguksam, black ginseng, purified ginseng ( Puffed ginseng), or enzyme-treated ginseng or a concentrate thereof.
상기 본 발명의 음료 조성물은 진세노사이드의 안정성을 높이기 위해 pH를 3.8 내지 8.0, 당도를 5.0 - 30.0 Brix로 하는 것이 바람직하다. 또한, 진세노사이드의 안정화제로서 L-아르기닌 또는 산미료를 더 포함하는 것이 바람직하다. 상기 산미료로는 음료의 제조에 통상적으로 이용되는 산미료가 이용될 수 있으며, 예를 들어 구연산, 구연산나트륨, 주석산, 사과산, 푸말산, 호박산, 글루콘산, 젖산, 초산, 비타민 C 등이 이용될 수 있다. 이와 같은 조건을 부여함으로써, 본 발명의 음료 조성물은 최종 소비자가 섭취 시에 상기 원하는 강화된 기능을 보다 신뢰성 있게 얻을 수 있다.In order to increase the stability of ginsenoside, the beverage composition of the present invention preferably has a pH of 3.8 to 8.0 and a sugar of 5.0 to 30.0 Brix. Moreover, it is preferable to further contain L-arginine or an acidulant as a stabilizer of ginsenoside. As the acidulant may be used acidic acid commonly used in the manufacture of beverages, for example citric acid, sodium citrate, tartaric acid, malic acid, fumaric acid, succinic acid, gluconic acid, lactic acid, acetic acid, vitamin C, etc. may be used. have. By imparting such conditions, the beverage composition of the present invention can more reliably obtain the desired enhanced function upon ingestion by the end consumer.
상기 본 발명의 기능성 음료 조성물은 바람직한 일 구현 예에 따르면, 인삼 추출물 0.05-15.0 %(w/w), 생약 농축액 0.01-15.0 %(w/w), 감미료 0.01-15.0 %(w/w), 벌꿀 0.05-5.0 %(w/w), 증점제 0.01-5.0 %(w/w), 착향료 0.01-0.5%(w/w) 및 물 49-99%(w/w)로 구성된다. The functional beverage composition of the present invention according to a preferred embodiment, ginseng extract 0.05-15.0% (w / w), herbal concentrate 0.01-15.0% (w / w), sweetener 0.01-15.0% (w / w), Honey 0.05-5.0% (w / w), thickener 0.01-5.0% (w / w), flavoring agent 0.01-0.5% (w / w) and water 49-99% (w / w).
상기 생약 농축액은 상기 진세노사이드 Rb1 또는 Rg1의 효능을 억제하지 않는다면 특히 제한되는 것은 아니며, 대추, 구기자, 황기, 당귀, 감초, 백복령, 숙지황, 계피, 생강, 및 이들의 조합으로부터 선택된 생약의 농축액일 수 있다. The herbal concentrate is not particularly limited so long as it does not inhibit the efficacy of the ginsenoside Rb1 or Rg1, and the concentrate of the herbal medicine selected from jujube, wolfberry, Astragalus, Angelica, licorice, Baekbokyeong, Sukjiwang, cinnamon, ginger, and combinations thereof Can be.
상기 증점제로는 음료에 통상적으로 이용되는 임의의 증점제가 이용될 수 있으며, 예를 들어 젤란검, 펙틴, 카라기난검, 결정셀룰로오스, 잔탄검, 덱스트린, 또는 이들의 조합 등이 이용될 수 있다. 상기 착향료 또한, 음료에 통상적으로 이용되는 임의의 착향료가 이용될 수 있으며, 예를 들어 인삼향, 홍삼향, 계피향, 대추향, 구기자향, 생약향, 드링크향 등이 이용될 수 있다. As the thickener, any thickener commonly used in beverages may be used. For example, gellan gum, pectin, carrageenan gum, crystalline cellulose, xanthan gum, dextrin, or a combination thereof may be used. The flavoring agent may also be any flavoring agent commonly used in beverages, for example, ginseng flavor, red ginseng flavor, cinnamon flavor, jujube flavor, goji berry flavor, herbal flavor, drink flavor and the like.
본 발명의 기능성 음료 조성물은 최종적인 살균을 위해 80-150℃에서 0.1-20 분간 살균할 수 있으며, 진세노사이드 Rb1과 Rg1의 안정성을 고려하면 130℃ 이하에서 1 분 이하로 살균하는 것이 바람직하다.Functional beverage composition of the present invention can be sterilized for 0.1-20 minutes at 80-150 ℃ for final sterilization, considering the stability of ginsenoside Rb1 and Rg1 is preferably sterilized at 130 ℃ or less for less than 1 minute. .
상기 설명한 바와 같이, 본 발명에 따른 음료 조성물은 인삼 추출물 중의 진세노사이드 Rb1 또는 Rg1의 함량이 선택적으로 강화되어, 체내에서 길항적으로 작용하는 Rb1 또는 Rg1의 효과를 높일 수 있다. 또한, 진세노사이드 Rb1 또는 Rg1의 효능 중 원하는 효능을 갖는 음료를 소비자가 본인의 체질 또는 상황에 맞춰 선택하여 섭취하도록 할 수 있으며, 유통기한 중의 진세노사이드의 손실을 최소화하여 신뢰성 높은 음료 조성물을 제공할 수 있다.As described above, the beverage composition according to the present invention can selectively enhance the content of ginsenoside Rb1 or Rg1 in the ginseng extract, thereby increasing the effect of Rb1 or Rg1 antagonistic action in the body. In addition, ginsenosides Rb1 or Rg1 of the efficacy of the desired efficacy of the beverage can be selected according to the user's constitution or situation, the consumer can be ingested, by minimizing the loss of ginsenosides in the expiration date for a reliable beverage composition Can provide.
이하, 본 발명을 하기 실시예에 의해 더욱 구체적으로 설명한다. 그러나, 이들 실시예는 본 발명에 대한 이해를 돕기 위한 것일 뿐, 어떤 의미로든 본 발명의 범위가 이들에 의해 제한되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to the following examples. However, these examples are only for the understanding of the present invention, and the scope of the present invention is not limited by them in any sense.
실시예Example 1 : One : Rb1Rb1 강화음료의 제조 Preparation of Fortified Drinks
[표 1] (단위 : %, w/w)[Table 1] (Unit:%, w / w)
상기 표 1의 조성을 함유하도록, 통상적인 음료의 제조 과정에 따라 각각의 원료를 투입하고 충분히 용해하고, 총량에 맞도록 정제수를 가하여 제품을 제조하고 110℃ 에서 30 초간 살균하여 제품을 완성하였다.In order to contain the composition of Table 1, according to the production process of the conventional beverage, each raw material was added and dissolved sufficiently, purified water was added to the total amount to prepare a product and sterilized at 110 ℃ for 30 seconds to complete the product.
상기 제조된 제품에 대해 저장 안정성을 평가한 결과 하기 표 2와 같은 결과를 얻었다. As a result of evaluating storage stability of the manufactured product, the results as shown in Table 2 were obtained.
[표 2] TABLE 2
상기 결과에 따르면, 제품 A와 같이 pH가 상대적으로 낮은 조건에서는 제조 및 보관 중에 진세노사이드의 손실이 다량 발생하였으며, 제품 B와 C의 경우는 비교적 안정하였다 According to the above results, a large amount of ginsenosides occurred during manufacture and storage under relatively low pH conditions such as product A, and products B and C were relatively stable.
또한, 관능 전문 연구원 20 인을 대상으로 하여 관능성 평가를 실시한 결과, 전반적인 맛 점수(5.0만점)에서 B는 3.7점, C는 4.0점으로 결과를 얻어 제품 B보다는 제품 C가 관능적으로 우수하다고 판단되었다. In addition, as a result of sensory evaluation of 20 sensory researchers, B score was 3.7 points and C score was 4.0 points in the overall taste score (500,000 points). It became.
실시예Example 2: L-아르기닌을 함유한 2: containing L-arginine Rb1Rb1 강화음료의 제조 Preparation of Fortified Drinks
[표 3] (단위: % w/w) Table 3 (Unit:% w / w)
상기 표 3의 조성을 함유하도록, 통상적인 음료의 제조 과정에 따라 각각의 원료를 투입하고 충분히 용해하고, 총량에 맞도록 정제수를 가하여 제품을 제조하고 110℃ 에서 30 초간 살균하여 제품을 완성하였다.In order to contain the composition of Table 3, according to the production process of a conventional beverage, each raw material was added and sufficiently dissolved, purified water was added to suit the total amount to prepare a product, and sterilized for 30 seconds at 110 ℃ to complete the product.
상기 제조된 제품에 대해 저장 안정성을 평가한 결과 하기 표 4와 같은 결과를 얻었다. As a result of evaluating storage stability of the manufactured product, the results as shown in Table 4 were obtained.
[표 4]TABLE 4
제조 후, 진세노사이드 분석 결과, L-아르기닌의 투입량에 따라 제조 후 시험기간 동안 잔존하는 진세노사이드의 양이 더 많은 것으로 확인되었고, 이는 pH 변화에 의한 것보다는 적은 영향이지만, 진세노사이드의 안정성에 영향을 미친다는 것을 보여준다. After preparation, the ginsenoside analysis showed that the amount of ginsenoside remaining during the post-preparation test period was higher depending on the dose of L-arginine, which was less affected than the pH change, Show stability.
실시예Example 3 : 3: Rg1Rg1 강화음료의 제조 Preparation of Fortified Drinks
[표 5] (단위: %, w/w)Table 5 (Unit:%, w / w)
상기 표 5의 조성을 함유하도록, 통상적인 음료의 제조 과정에 따라 각각의 원료를 투입하고 충분히 용해하고, 총량에 맞도록 정제수를 가하여 제품을 제조하고 110℃ 에서 30 초간 살균하여 제품을 완성하였다.In order to contain the composition of Table 5, according to the manufacturing process of the conventional beverage, each raw material was added and sufficiently dissolved, purified water was added to suit the total amount, and the product was prepared and sterilized at 110 ° C. for 30 seconds to complete the product.
상기 제조된 제품에 대해 저장 안정성을 평가한 결과 하기 표 6과 같은 결과를 얻었다. As a result of evaluating storage stability of the manufactured product, the results as shown in Table 6 were obtained.
[표 6]TABLE 6
상기 결과에 따르면, 제품 G와 같이 pH가 상대적으로 낮은 조건에서는 제조 및 보관 중에 진세노사이드의 손실이 다량 발생하였으며, 제품 H와 I의 경우는 비교적 안정하였다. According to the above results, a large amount of ginsenosides occurred during manufacture and storage under relatively low pH conditions such as product G, and products H and I were relatively stable.
또한, 관능 전문 연구원 20인을 대상으로 한 관능성 평가를 실시한 결과, 전반적인 맛 점수(5.0만점)에서 H는 3.6점, I는 3.9점으로 결과를 얻어 제품 H 보다는 제품 I가 관능적으로 우수하다고 판단되었다. In addition, as a result of sensory evaluation of 20 sensory researchers, H scores 3.6 and I scores 3.9 for overall taste scores (500,000 points). It became.
실시예Example 4: L-아르기닌을 함유한 4: containing L-arginine Rg1Rg1 강화음료의 제조 Preparation of Fortified Drinks
[표 7] (단위: %, w/w)TABLE 7 (Unit:%, w / w)
상기 표 7의 조성을 함유하도록, 통상적인 음료의 제조 과정에 따라 각각의 원료를 투입하고 충분히 용해하고, 총량에 맞도록 정제수를 가하여 제품을 제조하고 110℃ 에서 30 초간 살균하여 제품을 완성하였다.In order to contain the composition of Table 7, according to the production process of a conventional beverage, each raw material was added and sufficiently dissolved, purified water was added to suit the total amount to prepare a product, and sterilized for 30 seconds at 110 ℃ to complete the product.
상기 제조된 제품에 대해 저장 안정성을 평가한 결과 하기 표 8과 같은 결과를 얻었다. As a result of evaluating storage stability of the manufactured product, the results as shown in Table 8 were obtained.
[표 8]TABLE 8
제조 후, 진세노사이드 분석 결과, L-아르기닌의 투입량에 따라 제조 후 시험기간 동안 잔존하는 진세노사이드의 양이 더 많은 것으로 확인되었고, 이는 pH 변화에 의한 것보다는 적은 영향이지만, 진세노사이드의 안정성에 영향을 미친다는 것을 보여준다. After preparation, the ginsenoside analysis showed that the amount of ginsenoside remaining during the post-preparation test period was higher depending on the dose of L-arginine, which was less affected than the pH change, Show stability.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080084011A KR20100025303A (en) | 2008-08-27 | 2008-08-27 | Functional beverage composition in which the function of ginseng saponin is augmented |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080084011A KR20100025303A (en) | 2008-08-27 | 2008-08-27 | Functional beverage composition in which the function of ginseng saponin is augmented |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20100025303A true KR20100025303A (en) | 2010-03-09 |
Family
ID=42176879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080084011A KR20100025303A (en) | 2008-08-27 | 2008-08-27 | Functional beverage composition in which the function of ginseng saponin is augmented |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20100025303A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104187952A (en) * | 2014-08-14 | 2014-12-10 | 吉林省中医药科学院 | Ginseng-sealwort composite sports health beverage |
KR20150096079A (en) * | 2014-02-14 | 2015-08-24 | 주식회사 한국인삼공사 | Method for Making Red Ginseng Enriched with Ginsenoside Rg1 and Rb1, and Red Ginseng Obtained by the Same |
CN107410785A (en) * | 2017-08-14 | 2017-12-01 | 刘志二 | A kind of ginsenoside beverage that can quickly supplement physical efficiency |
CN115067407A (en) * | 2022-06-13 | 2022-09-20 | 杭州天草科技有限公司 | Anti-fatigue energy beverage |
KR20240109229A (en) | 2024-06-20 | 2024-07-10 | (주)에스제이파워 | Red ginseng extract that can prevent side effects of facial redness and its Preparing method |
-
2008
- 2008-08-27 KR KR1020080084011A patent/KR20100025303A/en not_active Application Discontinuation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150096079A (en) * | 2014-02-14 | 2015-08-24 | 주식회사 한국인삼공사 | Method for Making Red Ginseng Enriched with Ginsenoside Rg1 and Rb1, and Red Ginseng Obtained by the Same |
CN104187952A (en) * | 2014-08-14 | 2014-12-10 | 吉林省中医药科学院 | Ginseng-sealwort composite sports health beverage |
CN107410785A (en) * | 2017-08-14 | 2017-12-01 | 刘志二 | A kind of ginsenoside beverage that can quickly supplement physical efficiency |
CN115067407A (en) * | 2022-06-13 | 2022-09-20 | 杭州天草科技有限公司 | Anti-fatigue energy beverage |
KR20240109229A (en) | 2024-06-20 | 2024-07-10 | (주)에스제이파워 | Red ginseng extract that can prevent side effects of facial redness and its Preparing method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI500391B (en) | Composition for reliving and preventing hangover and beverage comprising composition | |
KR101326005B1 (en) | Functional beverage composition comprising Panax Ginseng concentrate and fruit concentrate | |
KR101392204B1 (en) | Composition comprising herbal extract of red ginseng, Angelicae gigantis Radix, citrus peel and green tea leaves for treating or preventing vascular diseases | |
US20220023376A1 (en) | Compositions for enhancing brain activity | |
RU2623629C2 (en) | Fatigue-relieving extracts of herbs and beverages containing them | |
KR20100025303A (en) | Functional beverage composition in which the function of ginseng saponin is augmented | |
KR101951402B1 (en) | Fermentative product of Sagunjatang having brain neuron cell-protective activity and uses thereof | |
KR101336094B1 (en) | Functional food composition for improving skin condition and preparation method thereof | |
KR20110051876A (en) | Composition having a detoxification effect on smoking | |
KR20170055614A (en) | A composition for preventing or treating menopausal cardiovascular disease comprising Cuscuta japonica Chois extract | |
CN109464540A (en) | A kind of alleviation oral cavity and the spray of throat discomfort and preparation method thereof | |
JP2004323439A (en) | Composition for ameliorating blood viscosity | |
KR20050100890A (en) | Composition comprising the extract of acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome | |
KR100930910B1 (en) | Beverage containing fresh Schisandra chinensis liquid and its manufacturing method | |
KR101076127B1 (en) | Pharmaceutical composition for detoxifying toxic substances caused by smoking which comprises extract of alnus japonica as an active component | |
KR101076482B1 (en) | Pharmaceutical composition for detoxifying toxic substances caused by smoking which comprises extract of sorbus commixta as an active component | |
KR20040004242A (en) | Use of the Ginseng extract | |
KR20130091387A (en) | Red ginseng sport beverage comprising panax ginseng concentrate and fruit concentrate | |
KR20170069404A (en) | Health beverages composing of extract from Ginseng berry and Astragali radix root and Method preparing thereof | |
KR20110012696A (en) | Food composition for stress relaxation, fatigue recovery or athletic performance enhancement comprising extract of root of vitis | |
KR102010858B1 (en) | Composition for preventing or treating hangover comprising extract from germinated gemmule of bean | |
WO2022040720A1 (en) | Caffeinated botanical infusion beverage and method of making same | |
KR101134200B1 (en) | Pharmaceutical composition for detoxifying toxic substances caused by smoking which comprises extract of hedyotis diffusa as an active component | |
KR101076515B1 (en) | Pharmaceutical composition for detoxifying toxic substances caused by smoking which comprises extract of lithospermum erythrorhizon as an active component | |
KR20100121566A (en) | Oriental herbal health food containing soybean embryo bud |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |